Advancing Towards Market
Advancing Towards Market
Read With Us
UC Irvine startup ReadWithUs uses AI-generated image descriptions to help blind parents read picture books with their...
Jill Kato October 19, 2026
Advancing Towards Market
StoryAI
UC Irvine startup StoryAI is designed to help young writers find their ideas without taking over the page
Jill Kato October 19, 2026
Advancing Towards Market
GlyTR
The Sweet Spot in Cancer Immunotherapy
Jill Kato August 28, 2026
Advancing Towards Market
The Problem with Good Enough
UC Irvine startup Cytoseen detects new drug targets for cancer and neurodegeneration.
Jill Kato June 15, 2026
Advancing Towards Market
Seeing the Unseen in Disease
UC Irvine startup Cytoseen detects new drug targets for cancer and neurodegeneration.
Jill Kato May 8, 2026
Advancing Towards Market
The Material Question
What if materials weren’t just made, but designed in tune with nature?
Jill Kato April 24, 2026
Advancing Towards Market
The Blind Spot in Modern Radiation Therapy
How UC Irvine startup SoundDose is tackling one of cancer care’s biggest unknowns
Jill Kato April 15, 2026
Advancing Towards Market
The $40 Trillion Question
Can MIFTI, a scrappy UC Irvine-based startup, outpace billion-dollar fusion giants?
Jill Kato March 30, 2026
Advancing Towards Market
A New Signal for Autism
How UC Irvine research and a father’s story are changing the timeline of care
Jill Kato February 27, 2026
Advancing Towards Market
Is This the Breakthrough Drug Development We’ve Been Waiting For?
Eira Bio is targeting membrane proteins long considered unreachable by antibody drugs.
Jill Kato February 17, 2026